IRIS
Gremese, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.489
AS - Asia 6.600
SA - Sud America 1.145
EU - Europa 1.072
Continente sconosciuto - Info sul continente non disponibili 327
AF - Africa 109
OC - Oceania 10
Totale 16.752
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.176
SG - Singapore 4.099
CN - Cina 1.158
BR - Brasile 923
VN - Vietnam 534
IT - Italia 345
HK - Hong Kong 240
GB - Regno Unito 137
CA - Canada 134
IN - India 114
DE - Germania 101
MX - Messico 80
BD - Bangladesh 77
AR - Argentina 75
RU - Federazione Russa 75
FR - Francia 64
IQ - Iraq 55
FI - Finlandia 48
EC - Ecuador 44
JP - Giappone 39
IE - Irlanda 37
CZ - Repubblica Ceca 36
MY - Malesia 35
ID - Indonesia 34
SE - Svezia 32
NL - Olanda 31
ZA - Sudafrica 31
CO - Colombia 30
PK - Pakistan 30
PL - Polonia 25
TR - Turchia 25
UA - Ucraina 25
VE - Venezuela 24
ES - Italia 21
PH - Filippine 21
NP - Nepal 19
LT - Lituania 18
MA - Marocco 17
GT - Guatemala 16
AT - Austria 15
CR - Costa Rica 15
CL - Cile 14
JM - Giamaica 14
PY - Paraguay 14
SA - Arabia Saudita 14
HN - Honduras 13
UZ - Uzbekistan 13
KR - Corea 12
NG - Nigeria 12
AZ - Azerbaigian 11
BE - Belgio 11
KE - Kenya 11
AE - Emirati Arabi Uniti 10
KZ - Kazakistan 9
AU - Australia 8
IL - Israele 8
PE - Perù 8
TH - Thailandia 8
EG - Egitto 7
JO - Giordania 7
NI - Nicaragua 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
CH - Svizzera 6
DO - Repubblica Dominicana 6
LV - Lettonia 6
BO - Bolivia 5
DK - Danimarca 5
DZ - Algeria 5
EE - Estonia 5
IR - Iran 5
RO - Romania 5
TN - Tunisia 5
ET - Etiopia 4
OM - Oman 4
SN - Senegal 4
SV - El Salvador 4
AL - Albania 3
CG - Congo 3
GR - Grecia 3
HR - Croazia 3
KH - Cambogia 3
PA - Panama 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
GD - Grenada 2
GE - Georgia 2
KG - Kirghizistan 2
KW - Kuwait 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
SC - Seychelles 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
Totale 16.403
Salva come PNG Salva come JPEG
Città #
Singapore 1.658
San Jose 1.283
Ashburn 917
The Dalles 626
Dallas 423
Council Bluffs 371
Beijing 324
Shanghai 293
Santa Clara 287
Hong Kong 225
Ho Chi Minh City 203
Los Angeles 130
Hanoi 118
Chandler 117
New York 107
Milan 90
São Paulo 77
Boardman 71
Phoenix 60
North Bergen 58
Brooklyn 49
Helsinki 47
Chicago 45
Rome 44
Montreal 39
Atlanta 38
London 37
Dublin 36
Wilmington 36
Rio de Janeiro 35
Buffalo 34
Mexico City 33
Toronto 32
Assago 28
Chennai 28
Princeton 28
Orem 27
Belo Horizonte 26
Frankfurt am Main 26
Stockholm 26
Tokyo 26
Brno 24
Campinas 23
Curitiba 23
Da Nang 23
Denver 23
San Francisco 23
Warsaw 23
Paris 21
Amsterdam 20
Charlotte 18
Haiphong 18
Houston 18
Munich 18
Naples 18
Philadelphia 18
Brasília 17
Seattle 17
Quito 16
San Diego 15
Baghdad 14
Johannesburg 14
Lahore 14
Lawrence 14
Reston 14
Salvador 14
Abbeville 13
Boston 13
Cleveland 13
Dhaka 13
Goiânia 13
Mumbai 13
New Delhi 13
San José 13
Ankara 12
Guatemala City 12
Kuala Lumpur 12
Las Vegas 12
Manchester 12
Olomouc 12
Tashkent 12
Baku 11
Biên Hòa 11
Brussels 11
Miami 11
Santo André 11
Detroit 10
Kingston 10
Moscow 10
Queens 10
San Mateo 10
Hangzhou 9
Hải Dương 9
Bologna 8
Cape Town 8
Guarulhos 8
Guayaquil 8
Kathmandu 8
Pasadena 8
Poplar 8
Totale 8.985
Salva come PNG Salva come JPEG
Nome #
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naive patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial 128
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials 125
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 116
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 105
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 104
Access of arthritis patients to an early arthritis clinic in three different settings: the very early ra represents the best clinical and therapeutic opportunity to reach das remission. Quality indicators (QI) of the italian ministry of health program 101
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 100
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine 97
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study 91
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 88
A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: A starter study post-hoc analysis 88
Cancer in connective tissue disease 86
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis. 85
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 85
Biologics use in SLE in 23 centers – data from the international registry for biologics in SLE 84
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study 84
QT and QT dispersion intervals in long-standing and moderately active rheumatoid arthritis: results from a multicentre cross-sectional study 82
Peripheral blood B cells subsets in patients with systemic lupus erythematosus: correlation with disease activity and organ involvement 78
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA. 78
B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids 77
ZAP70 B Cells and Plasmablasts As Markers of Disease Activity and Remission in Systemic LUPUS Erythematosus Nephritis 77
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis 77
Circulating Human Collagen II-Reactive T Cell in Early Rheumatoid Arthritis Produce IL17. 74
Results of the classification criteria for cryoglobulinemic vasculitis validation study 74
A brief battery for the evaluation of cognitive deficits in italian SLE patients 74
Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial 73
[Class IV-G and IV-S lupus nephritis, interstitial infiltrates and prognosis: state of the art and unmet medical needs] 73
ACPA–IL-6 as the best biomarkers to differentiate early rheumatoid arthritis from undifferentiated arthritis: analysis of the diagnostic performance 73
The Role of Microrna-34 and Microrna-22 in Dendritic Cells and Monocyte Activation in Rheumatoid Arthritis 73
CD19+ cells subsets (CD5, CD38 and CD23) in peripheral blood and synovial fluid of rheumatoid arthritis patients: relationship with disease activity and with auto-antibody levels 72
An unusual lung involvement in scleroderma: lipoid pneumonia 72
B-cell directed therapy in rheumatoid arthritis: predictive factors of efficacy and assessment of regeneration profile 72
A brief battery for the evaluation of cognitive deficits in italian SLE patients 72
Off-label use of rituximab for SLE in Europe: a comparison to patients treated with conventional immunosuppressive medications 71
B-cell depletion in rheumatoid arthritis: searching for serologic and clinical baseline factors that could predict long-term efficacy 71
Effectiveness of SB4 Transition from Originator Etanercept in Rheumatoid Arthritis and Axial Spondyloarthritis: A Subgroup Analysis from the BENEFIT Study 70
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 70
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: an IG-IBD study 70
Association of the 22 genotype of enhancer HS1,2A of the Ig heavy 3′ regulatory region with non response to DMARDS and response to rituximab in rheumatoid arthritis patients 69
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 69
The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmod 69
Validation Study Of The International Classification Criteria For The Cryoglobulinemic Vasculitis 68
The UltraSound-CLinical ARthritis Activity (US-CLARA) index: Properties of a new composite disease activity index for rheumatoid arthritis 68
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 68
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 68
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 68
ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature 68
The body mass index: a determinant of remission in early rheumatoid arthritis 68
Gene-gene interaction and early rheumatoid arthritis: effects on the response to therapy 67
Porphyromonas Gingivalis and the Pathogenesis of Rheumatoid Arthritis: Analysis of the Synovial Tissue and of Other Compartments 67
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 67
Anti-nucleosome antibodies: correlations with activity and chronicity disease indexes in systemic lupus erythematosus patients with renal involvement 67
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 67
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 67
Minimal disease activity in early and longstanding rheumatoid arthritis 66
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study 66
Adult onset Still's disease and pregnancy 66
Early rheumatoid arthritis (ERA) differs from long-standing RA (LSRA) in circulating B cell subsets. changes according to disease activity under conventional therapy 66
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 66
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 65
Antineutrophil cytoplasmic autoantibodies (ANCA) positivity as a red flag of severe disease in lupus nephritis 65
Renal inflammatory infiltrate in lupus nephritis patients 65
Anti-nucleosome antibodies: correlations with activity and chronicity disease indexes in systemic lupus erythematosus patients with renal involvement 65
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report 64
B cell activating factor (BAFF) and BAFF receptors: fakes and facts 64
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 64
Metabolic syndrome in autoimmune diseases: prevalence and relationship with the inflammatory burden 64
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 64
Tocilizumab in the treatment of arthritis: response to therapy and evaluation of B cells subsets after 4 months treatment 63
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 63
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 62
Distribution of body mass index and metabolic syndrome in patients with inflammatory autoimmune diseases from a single italian centre 62
Definition of fibromyalgia severity: Findings from a cross-sectional survey of 2339 Italian patients 62
ZAP-70 expression in B-cells during repopulation of peripheral blood following B-cell depletion in rheumatoid arthritis 62
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 62
Clinical nephritis remission is influenced by hepatocyte growth factor (HGF) and transforming growth factor-β1 (TGFβ1) renal tubular expression more than interstitial cell infiltrate in systemic lupus erythematosus (SLE) patients 61
Synovial fluid-derived TH17 cells correlate with disease activity in arthritis, irrespective of diagnosis 60
Long-term survival of anti-TNF therapy in a large italian cohort of rheumatoid arthritis patients: comparison among adalimumab, etanercept, and infliximab 60
Abatacept in the treatment of psoriatic arthritis: biological and clinical profiles (of the responders) 60
B-cell depletion in rheumatoid arthritis: searching for serologic and clinical baseline factors that could predict long-term efficacy 60
IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy 59
Driving chronicity in rheumatoid arthritis: Perpetuating role of myeloid cells 59
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 59
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 59
Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis 59
Circulating memory B cells characterize active nephritis instead activated naïve B cells are expanded in active articular involvement in patients with systemic lupus erythematosus (SLE) 59
Integrin alpha2bbeta3 gene polymorphism and the microvascular system in scleroderma 58
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 58
Metabolic syndrome in autoimmune diseases: prevalence and relationship with the inflammatory burden 58
Predictors, Features and Effects of First Biologic Switch in Rheumatoid Arthritis within GISEA register: Italian 10-Year Experience. 58
Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship? 58
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 58
Synovial membrane hypertrophy and power doppler positivity predict clinical relapse in long-standing RA patients reaching DAS disease remission under biologic treatment: prospective 5 years follow-up real-life analysis 58
Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries 58
Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis 57
Balance between hepatocyte growth factor (HGF) and transforming growth factor (TGF-BETA1) in renal biopsies of patients with lupus nephritis 57
Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis 57
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 56
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 56
CD19+ZAP70+ B cells value at baseline predicts response at T6 to BCDT (B cell depletion therapy). Recovery is mainly characterized by the appearance of naïve activated B cells and ZAP-70 positive B cells 56
Totale 7.079
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.254
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202227 0 0 0 6 0 1 1 3 3 5 4 4
2022/2023277 28 13 28 43 21 25 0 27 45 30 16 1
2023/2024726 11 13 54 15 1 32 18 9 5 7 19 542
2024/20253.279 181 27 136 64 58 271 173 176 705 800 347 341
2025/20269.262 1.220 618 470 621 355 458 2.546 362 501 778 719 614
2026/20273.118 316 608 1.529 665 0 0 0 0 0 0 0 0
Totale 16.752